HHS List of Promising Covid Drugs Excludes Hydroxychloroquine

July 13, 2020, 8:00 PM UTC

Promising therapies to combat the coronavirus include Gilead’s remdesivir, the generic steroid dexamethasone, and therapies that use plasma from people who have recovered from the virus, according to a list distributed by the HHS Dept.

  • Scientists are also studying whether monoclonal antibodies, hyperimmune globulin and heparin are effective against Covid-19
  • List doesn’t include hydroxychloroquine, which President Trump as recently as last week touted as a potential treatment despite multiple warnings of dangerous side effects from health officials and the FDA
  • NOTE: FDA revoked Emergency Use Authorization for hydroxychloroquine in June
  • Related: Gilead Says Remdesivir Linked to a Reduction in Mortality ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.